Effects of long-term vitamin K1 (phylloquinone) or vitamin K2 (menaquinone-4) supplementation on body composition and serum parameters in rats

Bone

Volumn 48, Issue 5, 2011, Pages 1036-1042

  Sogabe, Natsuko ^a,b   Maruyama, Rieko ^a   Baba, Otto ^c   Hosoi, Takayuki ^d   Goseki Sone, Masae ^a  

^a JAPAN WOMEN'S UNIVERSITY   (Japan)

^b KOMAZAWA WOMEN'S UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Bone mineral density; Bone strength; Fat accumulation; Growth hormone; Menaquinone 4; Phylloquinone; Vitamin k

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; CALCIUM; GROWTH HORMONE; MENATETRENONE; PHOSPHORUS; PHYTOMENADIONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE STRENGTH; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DIET SUPPLEMENTATION; DRY WEIGHT; FEMALE; FEMUR; IN VIVO STUDY; NONHUMAN; OSTEOPOROSIS; RAT; TRABECULAR BONE; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; BONE DENSITY; CHOLESTEROL; CYTOKINES; DIET; DIETARY SUPPLEMENTS; FEMALE; FEMUR; HORMONES; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SERUM; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES; VITAMIN K 1; VITAMIN K 2;

EID: 79954585466     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.01.020     Document Type: Article

References (50)

1. Booth S.L., Tucker K.L., Chen H., Hannan M.T., Gagnon D.R., Cupples L.A., et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 2000, 71:1201-1208.
2. Kaneki M., Hodges S.J., Hosoi T., Fujiwara S., Lyons A., Crean S.J., et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 2001, 17:315-321.
3. Berkner K.L., Pudota B.N. Vitamin K-dependent carboxylation of the carboxylase. Proc Natl Acad Sci USA 1998, 95:466-471.
4. Furie B., Bouchard B.A., Furie B.C. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999, 93:1798-1808.
5. Stanley T.B., Jin D.Y., Lin P.J., Stafford D.W. The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase. J Biol Chem 1999, 274:16940-16944.
6. Knobloch J.E., Suttie J.W. Vitamin K-dependent carboxylase. Control of enzyme activity by the "propeptide" region of factor X. J Biol Chem 1987, 262:15334-15337.
7. Berkner K.L. The vitamin K-dependent carboxylase. J Nutr 2000, 130:1877-1880.
8. Shearer M.J. The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Soc 1997, 56:915-937.
9. Binkley N.C., Suttie J.W. Vitamin K nutrition and osteoporosis. J Nutr 1995, 125:1812-1821.
10. Weber P. Management of osteoporosis: is there a role for vitamin K?. Int J Vitam Nutr Res 1997, 67:350-356.
11. Price P.A. Role of vitamin K-dependent proteins in bone metabolism. Annu Rev Nutr 1988, 8:565-583.
12. Kinoshita H., Nakagawa K., Narusawa K., Goseki-Sone M., Fukushi-Irie M., Mizoi L., et al. A functional single nucleotide polymorphism in the vitamin-K-dependent gamma-glutamyl carboxylase gene (Arg325Gln) is associated with bone mineral density in elderly Japanese women. Bone 2007, 40:451-456.
13. Sogabe N., Tsugawa N., Maruyama R., Kamao M., Kinoshita H., Okano T., et al. Nutritional effects of gamma-glutamyl carboxylase gene polymorphism on the correlation between the vitamin K status and gamma-carboxylation of osteocalcin in young males. J Nutr Sci Vitaminol 2007, 53:419-425.
14. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
15. Akiyama Y., Hara K., Ohkawa I., Tajima T. Effects of menatetrenone on bone loss induced by ovariectomy in rats. Jpn J Pharmacol 1993, 62:145-153.
16. Goseki-Sone M., Maruyama R., Sogabe N., Hosoi T. Effects of dietary lactose on long-term high-fat-diet-induced obesity in rats. Obesity 2007, 15:2605-2613.
17. Yamanouchi K., Yada E., Hozumi H., Ueno C., Nishihara M. Analyses of hind leg skeletons in human growth hormone transgenic rats. Exp Gerontol 2004, 39:1179-1188.
18. Gitelman H.J. An improved procedure for the determination of calcium in biological specimens. Anal Biochem 1967, 18:521-531.
19. Drewes P.A. Direct colorimetric determination of phosphorus in serum and urine. Clin Chem Acta 1972, 39:81-88.
20. Gornal A.G., Bardawill C.J., David M.M. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949, 177:751-766.
21. Bessey O.T., Lowry O.H., Brock M.J. A method for the rapid determination of alkaline phosphatase with five cubic millimeter of serum. J Biol Chem 1946, 164:321-329.
22. Pauly H.E., Pfleiderer G. d-glucose dehydrogenase from Bacillus megaterium M1286: purification, properties and structure. Hoppe Seylers Z Physiol Chem 1975, 356:1613-1623.
23. Spayd R.W., Bruschi B., Burdick B.A., Dappen G.M., Eikenberry J.N., Esders T.W., Figueras J., Goodhue C.T., LaRossa D.D., Nelson R.W., Rand R.N., Wu T.W. Mutilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem 1978, 24:1343-1350.
24. Allain C.C., Poon L.S., Chan C.S., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20:470-475.
25. Akedo Y., Hosoi T., Inoue S., Ikegami A., Mizuno Y., Kaneki M., et al. Vitamin K2 modulates proliferation and function of osteoblastic cells in vitro. Biochem Biophys Res Commun 1992, 187:814-820.
26. Koshihara Y., Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 1997, 12:431-438.
27. Koshihara Y., Hoshi K., Ishibashi H., Shiraki M. Vitamin K2 promotes 1alpha, 25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int 1996, 59:466-473.
28. Koshihara Y., Hoshi K., Okawara R., Ishibashi H., Yamamoto S. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol 2003, 176:339-348.
29. Hara K., Akiyama Y., Tajima T., Shiraki M. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. J Bone Miner Res 1993, 8:535-542.
30. Akiyama Y., Hara K., Tajima T., Murota S., Morita I. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur J Pharmacol 1994, 263:181-185.
31. Hara K., Akiyama Y., Nakamura T., Murota S., Morita I. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone 1995, 16:179-184.
32. Weinstein R.S. True strength. J Bone Miner Res 2000, 15:621-625.
33. Black D.M., Thompson D.E., Bauer D.C., Ensrud K., Musliner T., Hochberg M.C., et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 2000, 85:4118-4124.
34. Ettinger B., Black D.M., Mitlak B.H., Knickerbocker R.K., Nickelsen T., Genant H.K., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999, 282:637-645.
35. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785-795.
36. Tabb M.M., Sun A., Zhou C., Grün F., Errandi J., Romero K., et al. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003, 278:43919-43927.
37. Ichikawa T., Horie-Inoue K., Ikeda K., Blumberg B., Inoue S. Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem 2006, 281:16927-16934.
38. Sogabe N., Maruyama R., Hosoi T., Goseki-Sone M. Enhancement effects of vitamin K1 (phylloquinone) or vitamin K2 (menaquinone-4) on intestinal alkaline phosphatase activity in rats. J Nutr Sci Vitaminol 2007, 53:219-224.
39. Langman M.J., Leuthold E., Robson E.B., Harris J., Luffman J.E., Harris H. Influence of diet on the 'intestinal' component of serum alkaline phosphatase in people of different ABO blood groups and secretor status. Nature 1966, 212:41-43.
40. Goseki-Sone M., Oida S., Iimura T., Yamamoto A., Matsumoto H.N., Omi N., et al. Expression of mRNA encoding intestinal type alkaline phosphatase in rat liver and its increase by fat-feeding. Liver 1996, 16:358-364.
41. Narisawa S., Huang L., Iwasaki A., Hasegawa H., Alphers D.H., Millan J.L. Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol 2003, 23:7525-7530.
42. Geusens P.P., Boonen S. Osteoporosis and the growth hormone-insulin-like growth factor axis. Horm Res 2002, 58:49-55.
43. Monson J.P., Drake W.M., Carroll P.V., Weaver J.U., Rodriguez-Arnao J., Savage M.O. Influence of growth hormone on accretion of bone mass. Horm Res 2002, 58:52-56.
44. Olney R.C. Regulation of bone mass by growth hormone. Med Pediatr Oncol 2003, 41:228-234.
45. Takeuchi Y., Suzawa M., Fukumoto S., Fujita T. Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone 2000, 27:769-776.
46. Shearer M.J., Newman P. Metabolism and cell biology of vitamin K. Thromb Haemost 2008, 100:530-547.
47. Okano T., Shimomura Y., Yamane M., Suhara Y., Kamao M., Sugiura M., et al. Conversion of phylloquinone (vitamin K1) into menaquinone-4 (vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 2008, 283:11270-11279.
48. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
49. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008, 105:5266-5270.
50. Yoshida M., Jacques P.F., Meigs J.B., Saltzman E., Shea M.K., Gundberg C., et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diab Care 2008, 31:2092-2096.